Page last updated: 2024-11-02

pd 98059 and Leishmaniasis, Visceral

pd 98059 has been researched along with Leishmaniasis, Visceral in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghosh, S1
Bhattacharyya, S1
Sirkar, M1
Sa, GS1
Das, T1
Majumdar, D1
Roy, S1
Majumdar, S1

Other Studies

1 other study available for pd 98059 and Leishmaniasis, Visceral

ArticleYear
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.
    Infection and immunity, 2002, Volume: 70, Issue:12

    Topics: Animals; Cells, Cultured; Ceramides; Down-Regulation; Enzyme Inhibitors; Flavonoids; JNK Mitogen-Act

2002